OneFul Health, Inc.

Making Medicines Work Better For You - Personalized Medicines for as little as $1 a day.

Print
Claim My Business
Security Type
Equity
Categories
Consumer Products, Engineering & Technology, Health & Wellness, Healthcare/Medical, Physical Health, Science, Software, Technology
Min Investment
$250
Location
DURHAM, NC
Offering Date
February 24, 2023
Expected Close Date
June 01, 2023
Target Raise
$15.00K-$1.24M
No. Investors
76
Security Price
$1
Deal Notes

CEO/ Founder has multiple exits including participation on two IPO teams for technology companies. Strong executive team with both strong startup and operating experience. 

Valuation
$11,482,286
Website
oneful.health
Number of Employees
22
Cash
$243,120
Revenue
$3,937,387
Short Term Debt
$764,364
Cost of Goods
$1,782,680
Long Term Debt
$377,713
Net Income
$512,271

Company Description

OneFul is a pharmacy tech enterprise that has developed novel drug delivery products using patented automation and personalized medicine formulation software. In 2021, the company’s accredited pharma facility generated $5.8M in consolidated annual revenue and over $3.9 M thru 2022 in personalized medicine.

Amount Raised : $81,410
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Equity is a stock or any other security representing a direct ownership interest.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments